Key result
This review highlights that while metallic stents prevent chronic geometric remodeling, new approaches like drug-eluting stents and intravascular brachytherapy are needed to combat in-stent neointimal hyperplasia.
This review summarizes the mechanisms of restenosis following coronary angioplasty and highlights the evolution of treatments from balloon angioplasty to bare metal stents, drug-eluting stents, and brachytherapy.
Supports evolving stent technologies to address restenosis; leaves open optimal clinical application of drug-eluting stents and brachytherapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mun K. Hong (2001) conducted a review in Restenosis following coronary angioplasty. Strategies to combat restenosis (stents, drug-eluting stents, brachytherapy) was evaluated. This review highlights that while metallic stents prevent chronic geometric remodeling, new approaches like drug-eluting stents and intravascular brachytherapy are needed to combat in-stent neointimal hyperplasia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: